학술논문

Phase 2 study of first-line pembrolizumab in elderly patients with non-small cell lung cancer expressing high PD-L1.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2022, 40 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755